RBCC Explores NASA Technology in Stem Cell Search

NOKOMIS, Fla.--(BUSINESS WIRE)--

Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp. (RBCC), announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.

RBCC announced on Monday that it will expand its focus on technology capable of culturing 3D cell clusters to include adult stem cells. The company is currently investigating the potential for a bioreactor developed for the space program to grow tissues from adult stem cells for possible study and even transplantation. Stem cells grown using the NASA technology multiply rapidly and remain three dimensional, unlike the two-dimensional cells grown in Petri dishes.

This characteristic makes possible the production of healthy populations of cheaper and higher-quality stem cells suitable for all manner of research.

This technology has the potential to be one of NASAs greatest gifts to medical sciences, said RBCC CEO Patrick Brown. The ability to cultivate adult stem cells in a micro-gravity environment here on earth could prove to be a great leap forward in the field of biotechnology, and were very interested in discussing how we might be able to assist in the development and marketing of new therapies and other uses for this device.

According to a report published last year by analysts as GIA, global investments in adult stem-cell research are forecast to reach $2.4 billion by 2015. RBCC is currently exploring ways to capitalize on that growth. The company plans to develop technology to compete in the stem-cell research industry alongside Amgen, Inc. (AMGN), Celgene Corporation (CELG), Genzyme Corp. (NASDAQ:GENZ) and Gilead Sciences Inc. (GILD).

For more information on Rainbow BioSciences, please visit http://www.rainbowbiosciences.com/investors.html.

About Rainbow BioSciences

Rainbow BioSciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB:RBCC). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [www.RainbowBioSciences.com]. For investment information and performance data on the company, please visit http://www.RainbowBioSciences.com/investors.html.

Notice Regarding Forward-Looking Statements

See the article here:
RBCC Explores NASA Technology in Stem Cell Search